Adverse Drug Reaction Reporting Systems
"Adverse Drug Reaction Reporting Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
Below are MeSH descriptors whose meaning is more general than "Adverse Drug Reaction Reporting Systems".
Below are MeSH descriptors whose meaning is more specific than "Adverse Drug Reaction Reporting Systems".
This graph shows the total number of publications written about "Adverse Drug Reaction Reporting Systems" by people in this website by year, and whether "Adverse Drug Reaction Reporting Systems" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Adverse Drug Reaction Reporting Systems" by people in Profiles.
Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020 06 05; 11(1):32.
Introduction of a Mobile Adverse Event Reporting System Is Associated With Participation in Adverse Event Reporting. Am J Med Qual. 2019 Jan/Feb; 34(1):30-35.
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement. J Clin Oncol. 2018 02 20; 36(6):617-623.
Domperidone is Commonly Prescribed With QT-Interacting Drugs: Review of a Community-based Practice and a Postmarketing Adverse Drug Event Reporting Database. J Clin Gastroenterol. 2017 01; 51(1):56-62.
Attitudes and Usage of the Food and Drug Administration Adverse Event Reporting System Among Gastroenterology Nurse Practitioners and Physician Assistants. Gastroenterol Nurs. 2016 Jan-Feb; 39(1):25-31.
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project. Arthritis Care Res (Hoboken). 2015 Apr; 67(4):529-37.
Statins and cognitive function: a systematic review. Ann Intern Med. 2013 Nov 19; 159(10):688-97.
Infectious complications of TNF-a inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting System. J Gastrointestin Liver Dis. 2013 Sep; 22(3):269-76.
Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System. Aliment Pharmacol Ther. 2013 Aug; 38(4):388-96.
The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013 Jun; 108(6):866-72.